Try our Advanced Search for more refined results
Intellectual Property
-
September 20, 2023
Apple Prevails In Geolocation Patent Case
A Virginia federal judge has ruled in favor of Apple in a patent infringement lawsuit brought by Geoscope over patents relating to the geolocation of mobile devices, saying Geoscope's asserted patents cover abstract ideas.
-
September 20, 2023
TRO Nixed In Building Suppliers' Competition Dispute
A New York-based building supplier can't stop a California rival from allegedly bad-mouthing it to customers, a North Carolina state court judge has ruled, finding the Empire State company based its arguments for a temporary restraining order on speculation and hasn't shown the matter is an emergency.
-
September 20, 2023
Entertainment IP Veteran Joins Oppenheim & Zebrak In NYC
Litigation boutique Oppenheim & Zebrak LLP said Wednesday that the former vice president of copyright and legal affairs at the Motion Picture Association has joined the firm as a partner.
-
September 20, 2023
More Writers Sue OpenAI Alleging ChatGPT Infringes Their IP
OpenAI Inc. is facing more infringement allegations that the artificial intelligence research company is using protected works to train its generative AI product, ChatGPT, after a professional writers organization and a dozen best-selling authors filed a proposed copyright class action against it.
-
September 20, 2023
Target Gains Some Ground In Wireless IP Dispute At Fed. Circ.
The Federal Circuit ruled in favor of Target in a patent fight with the owner of a pair of wireless transaction patents, throwing out a finding that the company didn't show some claims were unpatentable and affirming a finding that some claims were unpatentable.
-
September 20, 2023
Ex-Gartner GC Joins RPCK To Lead Social Enterprise Group
RPCK Rastegar Panchal LLP, an international boutique firm that represents impact investors and entrepreneurs, announced Tuesday the hiring of the former executive vice president, general counsel and secretary of Gartner Inc., a business management consultant and research group.
-
September 20, 2023
Proud Boys Attys Except One Beat Research Co.'s Billing Suit
A jury research firm claiming that several Proud Boys' defense attorneys used one of its reports during their clients' Jan. 6 insurrection criminal case without paying for the work had its copyright infringement case mostly thrown out in D.C. federal court this week.
-
September 20, 2023
Basketball Academy Sues Ex-VP For Starting Rival Program
A professional basketball training academy filed suit in Ohio federal court Tuesday seeking a temporary restraining order against one of its former vice presidents over allegations that after he left the organization, he used proprietary information to start a competing program.
-
September 20, 2023
Fed. Circ. Hands Win To Roche In Blood Drug Fight
The Federal Circuit on Wednesday relied on the high court's recent Amgen ruling to side with a Delaware federal court decision that let a Roche subsidiary off the hook in an infringement case over its blockbuster hemophilia drug Hemlibra.
-
September 20, 2023
Amazon Beats Multimedia Patent Infringement Suit At Trial
A federal jury in Delaware has found Amazon and its Audible unit didn't infringe a multimedia patent through its music and Kindle platforms, and also found the patent itself wasn't valid to begin with.
-
September 20, 2023
Google Units Dropped From AI Development Suit
Two subsidiaries of Google were dropped earlier this week from a proposed class action in California federal court alleging that the tech giant used private and copyrighted information from hundreds of millions of Americans to train its generative artificial intelligence chatbot Bard.
-
September 20, 2023
Takeda Settles Gout Drug Antitrust Case Midtrial
Takeda Pharmaceuticals USA Inc. has reached a settlement with drug wholesalers in the middle of an antitrust trial in Pennsylvania federal court over the delayed entry of a generic version of its gout drug Colcrys, according to court filings.
-
September 20, 2023
Med Tech Biz Hit With Challenge To UK Heart Valve Patents
Indian medical device maker Meril has urged a court to invalidate two patents protecting the design of prosthetic heart valves owned by Edwards Lifesciences, which has brought infringement claims against Meril across five jurisdictions.
-
September 20, 2023
Newman Given 1-Year Suspension For Refusing Medical Tests
Federal Circuit Judge Pauline Newman was suspended Wednesday from hearing any cases for one year, after the court's other active judges said their 96-year-old colleague derailed an investigation into whether she is mentally fit to serve as judge by not agreeing to medical tests.
-
September 20, 2023
Orrick Adds MoFo Tech And Life Sciences IP Litigator In SF
Orrick Herrington & Sutcliffe LLP is expanding its West Coast team, bringing in a Morrison Foerster LLP intellectual property litigator as a partner in its San Francisco office.
-
September 19, 2023
Artist Takes Bold Copyright Move Against DC Comics
Comics creator Bill Willingham couldn't stand working with DC Comics any longer, so he released copyrights for one of his popular series into the public domain, a move that legal experts say is highly unorthodox but not surprising, given that publishers increasingly expect creators to relinquish their intellectual property rights.
-
September 19, 2023
Rapper's Girlfriend Used To Blow Up Vape Deal, Fla. Suit Says
A Florida e-cigarette company has accused a competitor of trying to ruin its business relationship with rapper Tekashi 6ix9ine, alleging in a state court lawsuit that the owners offered the rapper's girlfriend a cash bonus in an attempt to use his influence to market their products.
-
September 19, 2023
Eli Lilly Launches 10 Suits Over New Diabetes Drug
A little more than a year after releasing a popular billion-dollar drug marketed at people with Type 2 diabetes, Eli Lilly & Co. filed a flurry of lawsuits on Tuesday against spas and other retailers that it says are selling counterfeit or compounded versions of the drug as a weight loss cure.
-
September 19, 2023
Judge Tosses Hailey Bieber TM Row Amid Settlement Talks
A New York federal judge has agreed to toss a fashion brand's suit alleging model Hailey Bieber's skin care line Rhode infringed its trademarks, noting the parties have reached an agreement on the core terms of a settlement that will fully resolve the dispute.
-
September 19, 2023
Full 4th Circ. Refuses To Reconsider $48M Decision In IP Row
The full Fourth Circuit on Tuesday declined to revisit a split panel's recent decision backing a Virginia federal court order finding that an Atlanta hotel and real estate developer owes an engineering firm $48 million for using the same name, rejecting the developer's petition for a rehearing en banc.
-
September 19, 2023
Merck Chided By AARP, Democrats Over Drug Price Suit
The AARP, along with Democratic lawmakers and physician groups, lambasted Merck & Co. Inc.'s challenge to the Medicare drug price negotiation program on Tuesday, disputing the pharmaceutical company's constitutional arguments and saying it wants to eviscerate a program that will improve drug access and reduce federal spending.
-
September 19, 2023
TTAB Gives Health Group Partial Win In Registration Fight
The Trademark Trial and Appeal Board has reversed a decision that had rejected a Catholic health care group's bid to register the word "IMPACT" for things like charity measures and a website to provide medical information, but put a limit on another category for which it tried to get a registration.
-
September 19, 2023
Meta Slams Copyright Claims In Sarah Silverman's AI Suit
Meta Platforms Inc. wants a California federal court to mostly toss a copyright suit from stand-up comedian Sarah Silverman and a pair of authors over its AI product LLaMA, saying using words to train the system is fair use.
-
September 19, 2023
Takeda Wants End To Gout Drug Antitrust Case Midtrial
Takeda Pharmaceuticals is seeking an early end to an ongoing trial in an antitrust case brought by drug wholesalers over the delayed entry of a generic version of its gout drug Colcrys, claiming that underlying patent litigation and that lack of solid evidence pointing to a price-fixing conspiracy torpedo the plaintiffs' case.
-
September 19, 2023
Valeant Says 9th Circ.'s FCA Disclosure Ruling Went Too Far
The drugmaker behind a major bowel disease treatment said that a Ninth Circuit panel split with "at least eleven" other appeals courts when it ruled that putting together disclosures from patent proceedings could underpin a patent lawyer's use of whistleblower laws to go after the pharmaceutical company over claims of fraud.
Expert Analysis
-
Schumer Framework May Forge US Model On AI Governance
Senate Majority Leader Chuck Schumer's proposed SAFE Innovation Framework may have the potential to generate thoughtful understanding and governance of artificial intelligence within a meaningful time frame, say Alan Charles Raul and Rimsha Syeda at Sidley.
-
Trending At The PTAB: Cautionary Tale Of VLSI Challenger
The U.S. Patent and Trademark Office's sua sponte director review of the Patent Trial and Appeal Board's Patent Quality Assurance v. VLSI decision and the ensuing sanction order show that parties practicing before the PTAB should exercise clarity and consistency in their representations to avoid abuse-of-process findings, say attorneys at Finnegan.
-
Top 4 Employer AI Risks And How To Mitigate Them
The use of generative artificial intelligence by employees to perform their job duties presents significant challenges to their employers, so companies are now left to adapt their businesses, processes and procedures to address this useful but potentially disruptive technology, say Randi May and John Walpole at Tannenbaum Helpern.
-
The Basics Of Being A Knowledge Management Attorney
Excerpt from Practical Guidance
Michael Lehet at Ogletree Deakins discusses the role of knowledge management attorneys at law firms, the common tasks they perform and practical tips for lawyers who may be considering becoming one.
-
The Fed. Circ. In August: New Claim Constructions In IPR
The Federal Circuit's recent decision to vacate a Patent Trial and Appeal Board ruling in Axonics v. Medtronic clarifies inter partes review petitioners' ability to respond to new claim constructions proposed after an IPR is instituted, raising strategic considerations for patent owners and petitioners, say Justin Gillett and Paul Stewart at Knobbe Martens.
-
How 'Purely Legal' Issues Ruling Applies To Rule 12 Motions
The U.S. Supreme Court's recent Dupree v. Younger holding that purely legal issues resolved on summary judgment need not be reraised in post-trial motions guides litigators on when to preserve certain arguments for appeal, but raises the question of how Rule 12(b) and (c) motion denials will be affected, say Blaine Evanson and Jeremy Christiansen at Gibson Dunn.
-
Opinion
Generative AI Is Essential To Patent Industry's Sustainability
Ian Schick at Ethan Nathaniel discusses how stakeholders who leverage the power of generative AI now can flourish as the patent sector navigates the perfect storm of increased demand for patent applications and a declining number of early-career practitioners.
-
3 Lessons From Mock Trials That Attys Can Use In Practice
The hordes of data gleaned from mock trial competitions can isolate the methods that maximize persuasion, providing key principles that attorneys in every practice area can incorporate into their real-world trial work, say Spencer Pahlke at Walkup Melodia and Justin Bernstein at UCLA.
-
3 Areas Look Ripe For New SEP Licensing, Litigation
As we wait for standard-essential patent litigation over 5G, data compression and several other technologies have quietly developed elements that make them attractive to SEP holders, turning them into areas to watch for increased licensing and litigation in the near term, say Brian Johnson and Michael O’Mara at Axinn.
-
To Hire And Keep Top Talent, Think Beyond Compensation
Firms seeking to appeal to sophisticated clients and top-level partners should promote mentorship, ensure that attorneys from diverse backgrounds feel valued, and clarify policies about at-home work, says Patrick Moya at Quaero Group.
-
4 Ways Generative AI May Implicate Trademarks
Attorneys at Covington consider generative AI's impact on intellectual property infringement as it applies to the trademark arena, assessing the risks of compromises in key scenarios including when AI-generated output is related to another entity's marks, goods or services.
-
Opinion
The Risks In Policymakers' Focus On Multiple PTAB Petitions
Congress' and the U.S. Patent and Trademark Office's singular focus on reducing multiple Patent Trial and Appeal Board petitions represents an overcorrection, creating unsound rules and statutes that will inevitably disrupt the patent system's balance even further, says Ashraf Fawzy at Unified Patents.
-
A Closer Look At China's Landmark Pharma Antitrust Ruling
The Supreme People's Court's recent decision in Yangtze River Pharma v. HIPI Pharma — the first antitrust litigation in China's active pharmaceutical ingredient sector — indicates a balanced regulatory approach between competition concerns and intellectual property rights protection, say analysts at The Brattle Group.
-
Perspectives
More States Should Join Effort To Close Legal Services Gap
Colorado is the most recent state to allow other types of legal providers, not just attorneys, to offer specific services in certain circumstances — and more states should rethink the century-old assumptions that shape our current regulatory rules, say Natalie Anne Knowlton and Janet Drobinske at the University of Denver.
-
Balancing SEC Cyber Compliance And Trade Secret Protection
The U.S. Securities and Exchange Commission’s recently adopted rules requiring the disclosure of material cybersecurity incidents could implicate trade secrets, meaning companies should consider how to comply without compromising confidential information, say Daniel Garrie at Law & Forensics and Bradford Newman at Baker McKenzie.